Developing Drugs for Tissue‐Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine

por Seligson, Nathan D., Knepper, Todd C., Ragg, Susanne, Walko, Christine M.
Publicado 2020

Development of a Campus-Wide Community Service Initiative during a Pandemic

por King, Kevan, Davis, Hannah E., Moorman-Li, Robin, Cook, Kelsey J., Seligson, Nathan D.
Publicado 2022

Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges

por Hsu, Jocelyn Y., Seligson, Nathan D., Hays, John L., Miles, Wayne O., Chen, James L.
Publicado 2022

Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives

por Faheem, Mir Mohd, Seligson, Nathan D., Ahmad, Syed Mudabir, Rasool, Reyaz Ur, Gandhi, Sumit G., Bhagat, Madhulika, Goswami, Anindya
Publicado 2020

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma

por Seligson, Nathan D., Stets, Colin W., Demoret, Bryce W., Awasthi, Achal, Grosenbacher, Nicholas, Shakya, Reena, Hays, John L., Chen, James L.
Publicado 2019

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target

por Seligson, Nathan D., Maradiaga, Richard D., Stets, Colin M., Katzenstein, Howard M., Millis, Sherri Z., Rogers, Alan, Hays, John L., Chen, James L.
Publicado 2021

Gene partners of the EWSR1 fusion may represent molecularly distinct entities

por Walker, Victoria, Jin, Dexter X., Millis, Sherri Z., Nasri, Elham, Corao-Uribe, Diana A., Tan, Aik Choon, Fridley, Brooke L., Chen, James L., Seligson, Nathan D.
Publicado 2023

Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma

por Seligson, Nathan D., Awasthi, Achal, Millis, Sherri Z., Turpin, Brian K., Meyer, Christian F., Grand'Maison, Anne, Liebner, David A., Hays, John L., Chen, James L.
Publicado 2019

UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation

por Nelson, Ryan S., Seligson, Nathan D., Bottiglieri, Sal, Carballido, Estrella, Cueto, Alex Del, Imanirad, Iman, Levine, Richard, Parker, Alexander S., Swain, Sandra M., Tillman, Emma M., Hicks, J. Kevin
Publicado 2021

Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas

por Seligson, Nathan D., Tang, Joy, Jin, Dexter X., Bennett, Monica P., Elvin, Julia A., Graim, Kiley, Hays, John L., Millis, Sherri Z., Miles, Wayne O., Chen, James L.
Publicado 2022

PARP1 and POLD2 as prognostic biomarkers for multiple myeloma in autologous stem cell transplant

por Thomas, Melissa, Li, Junan, King, Kevan, Persaud, Avinash K., Duah, Ernest, Vangundy, Zachary, Hofmeister, Craig C., Lamba, Jatinder K., Tan, Aik Choon, Fridley, Brooke L., Poi, Ming J., Seligson, Nathan D.
Publicado 2023

Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institution

por Cook, Kelsey J., Grusauskas, Victoria, Gloe, Lucy, Duong, Benjamin Q., Gresh, Renee C., Kolb, E. Anders, Bansal, Manisha, Bechtel, Allison S., Nagasubramanian, Ramamoorthy, Kirwin, Susan M., Blake, Kathryn V., Seligson, Nathan D.
Publicado 2023

Recommendations for patient similarity classes: results of the AMIA 2019 workshop on defining patient similarity

por Seligson, Nathan D, Warner, Jeremy L, Dalton, William S, Martin, David, Miller, Robert S, Patt, Debra, Kehl, Kenneth L, Palchuk, Matvey B, Alterovitz, Gil, Wiley, Laura K, Huang, Ming, Shen, Feichen, Wang, Yanshan, Nguyen, Khoa A, Wong, Anthony F, Meric-Bernstam, Funda, Bernstam, Elmer V, Chen, James L
Publicado 2020